-
Soliton Responds To Blog Calling It A 'PR Machine'
Friday, May 17, 2019 - 11:57am | 431Medical device company Soliton, Inc. (NASDAQ: SOLY) reacted Friday to a blog post calling the firm a "PR machine" and addressed whether it can achieve Food and Drug Administration clearance to market its new Rapid Acoustic Pulse technology. RAP technology has the ...
-
A New Short Report Claims Transenterix's Senhance System Is A 'Commercial Flop'
Tuesday, November 14, 2017 - 1:04pm | 631A new report from White Diamond Research throws some shade on Transenterix Inc (NYSE: TRXC) and its Senhance System. Transenterix stock is up 111 percent since it gained FDA approval for Senhance in October, but White Diamond says European doctors have nothing but bad things to say about the...